Enzo Biochem, Inc. (NYSE: ENZ) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference
Enzo Biochem (NYSE: ENZ) is an integrated life science and biotechnology company engaged in the R&D, manufacture and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company operates in three segments: Clinical Labs, which provides routine and esoteric clinical laboratory tests or procedures used in general patient care to establish or support a diagnosis; Life Sciences, which manufactures, develops, and markets products and tools to life sciences, drug development, and clinical research customers; and Therapeutics, which is involved in the research and development of therapeutic drug candidates in the areas of gastrointestinal, infectious,…
